http://www.ardelyx.com
Ardelyx, Inc. Company Intro
Industry
Healthcare
Ardelyx, Inc. Headquaters
34175 Ardenwood Boulevard
Fremont,94555
United States
Ardelyx, Inc. Share price
02 Dec 2021 09:20 GMT
$1.4000
0.26 (22.81 %)
Ardelyx, Inc. Market cap
$121.387 M
WMC RANKING
2021
Ardelyx, Inc. # 178
BiotechnologyLatest Ardelyx, Inc. News
01 Dec 2021
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2021 - Benzinga
Upgrades Goldman Sachs upgraded the previous rating for Grupo Aeroportuario del Sureste SAB de CV.
01 Dec 2021
Ardelyx Plans to Launch IBSRELA to Treat IBS-C in Q2 2022
Ardelyx, Inc. (NASDAQ: ARDX) has reported plans to launch IBSRELA, the approved treatment for irritable bowel syndrome with constipation (IBS-C) in adults...
01 Dec 2021
ARDX Stock Alert: The IBS Drug News Sending Ardelyx Shares Soaring Today
Ardelyx (ARDX) stock is soaring higher on Wednesday following an update concerning the company's ISB-C treatment in adults.
WMC Market Score
WMC Market to Revenue Score
Ardelyx, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Ardelyx, Inc. | USD | $12,940 | $112,811 | $-105,095 | $1,214M | 178 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $673,660B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $515,660B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $142,860B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Ardelyx, Inc. Social Followers vs Top 4 Industry Competitors
Ardelyx, Inc. Post vs Top 4 Industry Competitors
Ardelyx, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Ardelyx, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Ardelyx, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Ardelyx, Inc. | 0.14 | 2.60 | 0.02 | 0 | 0 | 0 | 1.01 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 100 | 0 | 0 | 54.46 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 86 | 0 | 0 | 50.16 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 60 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 2 | 0 | 0 | 2.88 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
